Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 310

1.

Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study.

Zoccali C, D'Arrigo G, Pizzini P, Postorino M, Tripepi G, Mallamaci F.

J Hypertens. 2019 Jan 9. doi: 10.1097/HJH.0000000000002030. [Epub ahead of print]

PMID:
30633126
2.

Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in Chronic Kidney Disease Patients.

Mallamaci F, Tripepi G, D'Arrigo G, Borrelli S, Garofalo C, Stanzione G, Provenzano M, De Nicola L, Conte G, Minutolo R, Zoccali C.

Clin J Am Soc Nephrol. 2019 Jan 2. pii: CJN.04030318. doi: 10.2215/CJN.04030318. [Epub ahead of print]

PMID:
30602461
3.

Author Correction: Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2018 Dec 11. doi: 10.1038/s41581-018-0099-y. [Epub ahead of print]

PMID:
30538326
4.

Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study.

Mallamaci F, Tripepi R, D'Arrigo G, Porto G, Versace MC, Marino C, Sanguedolce MC, Testa A, Tripepi G, Zoccali C.

Nephrol Dial Transplant. 2018 Nov 23. doi: 10.1093/ndt/gfy355. [Epub ahead of print]

PMID:
30476170
5.

The dominant prognostic value of physical functioning among quality of life domains in end-stage kidney disease.

Torino C, Panuccio V, Tripepi R, Vilasi A, Postorino M, Tripepi G, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2018 Nov 15. doi: 10.1093/ndt/gfy334. [Epub ahead of print]

PMID:
30445469
6.

Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update.

Coppo R, D'Arrigo G, Tripepi G, Russo ML, Roberts ISD, Bellur S, Cattran D, Cook TH, Feehally J, Tesar V, Maixnerova D, Peruzzi L, Amore A, Lundberg S, Di Palma AM, Gesualdo L, Emma F, Rollino C, Praga M, Biancone L, Pani A, Feriozzi S, Polci R, Barratt J, Del Vecchio L, Locatelli F, Pierucci A, Caliskan Y, Perkowska-Ptasinska A, Durlik M, Moggia E, Ballarin JC, Wetzels JFM, Goumenos D, Papasotiriou M, Galesic K, Toric L, Papagianni A, Stangou M, Benozzi L, Cusinato S, Berg U, Topaloglu R, Maggio M, Ots-Rosenberg M, D'Amico M, Geddes C, Balafa O, Quaglia M, Cravero R, Lino Cirami C, Fellstrom B, Floege J, Egido J, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2018 Nov 9. doi: 10.1093/ndt/gfy302. [Epub ahead of print]

PMID:
30418652
7.

Lipid management in patients with chronic kidney disease.

Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C.

Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. Review. Erratum in: Nat Rev Nephrol. 2018 Dec 11;:.

PMID:
30361677
8.

Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: a secondary analysis of the EXCITE trial.

Baggetta R, D'Arrigo G, Torino C, ElHafeez SA, Manfredini F, Mallamaci F, Zoccali C, Tripepi G; EXCITE Working group.

BMC Geriatr. 2018 Oct 20;18(1):248. doi: 10.1186/s12877-018-0938-5.

9.

Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients.

Torino C, Pizzini P, Cutrupi S, Postorino M, Tripepi G, Mallamaci F, Reiser J, Zoccali C; PROGREDIRE Working Group.

Kidney Int Rep. 2018 May 22;3(5):1100-1109. doi: 10.1016/j.ekir.2018.05.004. eCollection 2018 Sep.

10.

A New Treatment for Calciphylaxis in Hemodialysis Patients?

Zoccali C, Mallamaci F.

Am J Nephrol. 2018;48(3):165-167. doi: 10.1159/000491882. Epub 2018 Sep 3. No abstract available.

11.

Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.

Sarafidis PA, Mallamaci F, Loutradis C, Ekart R, Torino C, Karpetas A, Raptis V, Bikos A, Papagianni A, Balafa O, Siamopoulos K, Pisani G, Morosetti M, Del Giudice A, Aucella F, Di Lullo L, Tripepi R, Tripepi G, Jager K, Dekker F, London G, Zoccali C.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1872. doi: 10.1093/ndt/gfy263. No abstract available.

PMID:
30113666
12.

Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease: Managing Volume Overload.

Zoccali C, Mallamaci F.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1432-1434. doi: 10.2215/CJN.01360118. Epub 2018 Aug 15. No abstract available.

PMID:
30111588
13.

Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics.

Provenzano M, Chiodini P, Minutolo R, Zoccali C, Bellizzi V, Conte G, Locatelli F, Tripepi G, Del Vecchio L, Mallamaci F, Di Micco L, Russo D, Heerspink HJL, De Nicola L; Collaborative Study Group on the Conservative Treatment of CKD of the Italian Society of Nephrology.

Nephrol Dial Transplant. 2018 Jul 23. doi: 10.1093/ndt/gfy217. [Epub ahead of print]

PMID:
30053127
14.

Prevalence and control of hypertension by 48-h ambulatory blood pressure monitoring in haemodialysis patients: a study by the European Cardiovascular and Renal Medicine (EURECA-m) working group of the ERA-EDTA.

Sarafidis PA, Mallamaci F, Loutradis C, Ekart R, Torino C, Karpetas A, Raptis V, Bikos A, Papagianni A, Balafa O, Siamopoulos K, Pisani G, Morosetti M, Del Giudice A, Aucella F, Di Lullo L, Tripepi R, Tripepi G, Jager K, Dekker F, London G, Zoccali C.

Nephrol Dial Transplant. 2018 Jul 10. doi: 10.1093/ndt/gfy147. [Epub ahead of print]

PMID:
30007295
15.

Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease.

Borrelli S, Garofalo C, Mallamaci F, Tripepi G, Stanzione G, Provenzano M, Conte G, De Nicola L, Zoccali C, Minutolo R.

J Hypertens. 2018 Dec;36(12):2398-2405. doi: 10.1097/HJH.0000000000001825.

PMID:
29995698
16.

Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses.

Grassi G, Pisano A, Bolignano D, Seravalle G, D'Arrigo G, Quarti-Trevano F, Mallamaci F, Zoccali C, Mancia G.

Hypertension. 2018 Aug;72(2):483-491. doi: 10.1161/HYPERTENSIONAHA.118.11038. Epub 2018 Jun 18.

PMID:
29915014
17.

Pulse Wave Velocity and Prognosis in End-Stage Kidney Disease.

Tripepi G, Agharazii M, Pannier B, D'Arrigo G, Mallamaci F, Zoccali C, London G.

Hypertension. 2018 Jun;71(6):1126-1132. doi: 10.1161/HYPERTENSIONAHA.118.10930. Epub 2018 Apr 30.

PMID:
29712739
18.

The sirtuin1 gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study.

Spoto B, Ntounousi E, Testa A, Liakopoulos V, D'Arrigo G, Tripepi G, Parlongo RM, Sanguedolce MC, Mallamaci F, Zoccali C.

J Hypertens. 2018 Aug;36(8):1705-1711. doi: 10.1097/HJH.0000000000001746.

PMID:
29702498
19.

Obestatin, a Ghrelin-Cognate Protein, and Clinical Outcomes in Hemodialysis Patients.

Zoccali C, Mallamaci F.

Am J Nephrol. 2018;47(4):251-253. doi: 10.1159/000488287. Epub 2018 Apr 25. No abstract available.

20.

Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial.

D'arrigo G, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2018 Apr 13. doi: 10.1093/ndt/gfy085. [Epub ahead of print]

PMID:
29668990
21.

Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term.

Rossi GP, Maiolino G, Flego A, Belfiore A, Bernini G, Fabris B, Ferri C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Muiesan ML, Mannelli M, Negro A, Palumbo G, Parenti G, Rossi E, Mantero F; PAPY Study Investigators.

Hypertension. 2018 Apr;71(4):585-591. doi: 10.1161/HYPERTENSIONAHA.117.10596. Epub 2018 Feb 26.

PMID:
29483224
22.

Moderator's view: Low-protein diet in chronic kidney disease: effectiveness, efficacy and precision nutritional treatments in nephrology.

Zoccali C, Mallamaci F.

Nephrol Dial Transplant. 2018 Mar 1;33(3):387-391. doi: 10.1093/ndt/gfx374.

PMID:
29471510
23.

Neuropeptide Y and chronic kidney disease progression: a cohort study.

Zoccali C, D'Arrigo G, Leonardis D, Pizzini P, Postorino M, Tripepi G, Mallamaci F, van den Brand J, van Zuilen A, Wetzels J, Bots ML, Blankestijn P.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1805-1812. doi: 10.1093/ndt/gfx351.

PMID:
29370406
24.

Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients.

Torino C, Pizzini P, Cutrupi S, Tripepi R, Vilasi A, Tripepi G, Mallamaci F, Zoccali C.

Oxid Med Cell Longev. 2017;2017:2801324. doi: 10.1155/2017/2801324. Epub 2017 Dec 6.

25.

Vitamin D receptor activation by paricalcitol and insulin resistance in CKD.

Spoto B, Pizzini P, Cutrupi S, Tripepi G, Curatola G, Mallamaci F, Zoccali C.

Nutr Metab Cardiovasc Dis. 2018 Mar;28(3):291-297. doi: 10.1016/j.numecd.2017.11.010. Epub 2017 Dec 7.

PMID:
29307660
26.

Circulating adiponectin modifies the FGF23 response to vitamin D receptor activation: a post hoc analysis of a double-blind, randomized clinical trial.

Spoto B, Pizzini P, Tripepi G, Mallamaci F, Zoccali C.

Nephrol Dial Transplant. 2018 Oct 1;33(10):1764-1769. doi: 10.1093/ndt/gfx344.

PMID:
29304245
27.

Uric acid in chronic kidney disease: the quest for causality continues.

Zoccali C, Mallamaci F.

Nephrol Dial Transplant. 2018 Feb 1;33(2):193-195. doi: 10.1093/ndt/gfx341. No abstract available.

PMID:
29294051
28.

The overdriven glomerulus as a cardiovascular risk factor.

Zoccali C, Mallamaci F.

Kidney Int. 2018 Jan;93(1):13-15. doi: 10.1016/j.kint.2017.08.035.

PMID:
29291815
29.

Validation of echocardiographic criteria for the clinical diagnosis of heart failure in chronic kidney disease.

Untersteller K, Seiler-Mußler S, Mallamaci F, Fliser D, London GM, Zoccali C, Heine GH.

Nephrol Dial Transplant. 2017 Jul 5. doi: 10.1093/ndt/gfx197. [Epub ahead of print]

PMID:
29106648
30.

Optimizing hypertension management in renal transplantation: a call to action.

Halimi JM, Persu A, Sarafidis PA, Burnier M, Abramowicz D, Sautenet B, Oberbauer R, Mallamaci F, London G, Rossignol P, Wuerzner G, Watschinger B, Zoccali C.

Nephrol Dial Transplant. 2017 Dec 1;32(12):1959-1962. doi: 10.1093/ndt/gfx283. No abstract available.

PMID:
29099945
31.

Optimizing hypertension management in renal transplantation: a call to action.

Halimi JM, Persu A, Sarafidis PA, Burnier M, Abramowicz D, Sautenet B, Oberbauer R, Mallamaci F, London G, Rossignol P, Wuerzner G, Watschinger B, Zoccali C; European Renal, Cardiovascular Medicine (EURECA-m), the transplant DESCARTES working group of the European Renal Association-European Dialysis, Transplant Association (ERA-EDTA), the Working Group ‘Hypertension, Kidney’ of the European Society of Hypertension (ESH); the EKITA committee of the European Society of Organ Transplantation (ESOT), FCRIN INI-CRCT Cardiovascular, Renal Clinical Trialists.

J Hypertens. 2017 Dec;35(12):2335-2338. doi: 10.1097/HJH.0000000000001586. No abstract available.

PMID:
29095226
32.

Background Dietary Patterns and the Time Course of the Blood Pressure Response to Low Sodium Intake.

Zoccali C, Mallamaci F.

Hypertension. 2017 Nov;70(5):890-892. doi: 10.1161/HYPERTENSIONAHA.117.10129. No abstract available.

PMID:
28993447
33.

Vitamin D and methylarginines in chronic kidney disease (CKD).

Torino C, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F, Zoccali C.

PLoS One. 2017 Oct 4;12(10):e0185449. doi: 10.1371/journal.pone.0185449. eCollection 2017.

34.

Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients.

Mallamaci F, D'Arrigo G, Tripepi R, Leonardis D, Porto G, Testa A, Abd ElHafeez S, Mafrica A, Versace MC, Provenzano PF, Tripepi G, Mancini P, Zoccali C.

J Hypertens. 2018 Jan;36(1):119-125. doi: 10.1097/HJH.0000000000001530.

PMID:
28858982
35.

Propensity to calcification as a pathway to renal hypoxia in chronic kidney disease and in hypertension.

Zoccali C, Mallamaci F.

J Hypertens. 2017 Oct;35(10):1963-1965. doi: 10.1097/HJH.0000000000001413. No abstract available.

PMID:
28858199
36.

Sympathetic nerve traffic and blood pressure changes after bilateral renal denervation in resistant hypertension: a time-integrated analysis.

Seravalle G, D'Arrigo G, Tripepi G, Mallamaci F, Brambilla G, Mancia G, Grassi G, Zoccali C.

Nephrol Dial Transplant. 2017 Aug 1;32(8):1351-1356. doi: 10.1093/ndt/gfx200.

PMID:
28810724
37.

Clinical News.

Fricker J, Moore M, Bennett SJ, Mallamaci F, Lyon S, Fizazi K, Fricker J.

Br J Hosp Med (Lond). 2017 Jul 2;78(7):368-371. doi: 10.12968/hmed.2017.78.7.368. No abstract available.

PMID:
28692364
38.

[Pulmonary congestion and hypertension in hemodialysis patients].

Mallamaci F, Tripepi G.

G Ital Nefrol. 2017 Mar;34(Suppl 69):36-40. Italian.

PMID:
28682027
39.

Intact FGF23 and α-klotho during acute inflammation/sepsis in CKD patients.

Dounousi E, Torino C, Pizzini P, Cutrupi S, Panuccio V, D'Arrigo G, Abd ElHafeez S, Tripepi G, Mallamaci F, Zoccali C.

Eur J Clin Invest. 2017 Jun;47(6):470-472. doi: 10.1111/eci.12765. No abstract available.

PMID:
28489248
40.

Chronic Fluid Overload and Mortality in ESRD.

Zoccali C, Moissl U, Chazot C, Mallamaci F, Tripepi G, Arkossy O, Wabel P, Stuard S.

J Am Soc Nephrol. 2017 Aug;28(8):2491-2497. doi: 10.1681/ASN.2016121341. Epub 2017 May 4.

41.

The systemic nature of CKD.

Zoccali C, Vanholder R, Massy ZA, Ortiz A, Sarafidis P, Dekker FW, Fliser D, Fouque D, Heine GH, Jager KJ, Kanbay M, Mallamaci F, Parati G, Rossignol P, Wiecek A, London G; European Renal and Cardiovascular Medicine (EURECA-m) Working Group of the European Renal Association – European Dialysis Transplantation Association (ERA-EDTA).

Nat Rev Nephrol. 2017 Jun;13(6):344-358. doi: 10.1038/nrneph.2017.52. Epub 2017 Apr 24. Review.

PMID:
28435157
42.

Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).

Sarafidis PA, Persu A, Agarwal R, Burnier M, de Leeuw P, Ferro CJ, Halimi JM, Heine GH, Jadoul M, Jarraya F, Kanbay M, Mallamaci F, Mark PB, Ortiz A, Parati G, Pontremoli R, Rossignol P, Ruilope L, Van der Niepen P, Vanholder R, Verhaar MC, Wiecek A, Wuerzner G, London GM, Zoccali C.

Nephrol Dial Transplant. 2017 Apr 1;32(4):620-640. doi: 10.1093/ndt/gfw433. Review.

PMID:
28340239
43.

Cholesterol: Another Salty Pathway to Cardiovascular Disease?

Zoccali C, Mallamaci F.

Arterioscler Thromb Vasc Biol. 2017 Mar;37(3):383-384. doi: 10.1161/ATVBAHA.117.308913. No abstract available.

PMID:
28228441
44.

Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH).

Sarafidis PA, Persu A, Agarwal R, Burnier M, de Leeuw P, Ferro C, Halimi JM, Heine G, Jadoul M, Jarraya F, Kanbay M, Mallamaci F, Mark PB, Ortiz A, Parati G, Pontremoli R, Rossignol P, Ruilope L, Van der Niepen P, Vanholder R, Verharr MC, Wiecek A, Wuerzner G, London GM, Zoccali C.

J Hypertens. 2017 Apr;35(4):657-676. doi: 10.1097/HJH.0000000000001283.

PMID:
28157814
45.

Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels.

Torino C, Pizzini P, Cutrupi S, Tripepi G, Mallamaci F, Thadhani R, Zoccali C.

Nutr Metab Cardiovasc Dis. 2017 Mar;27(3):260-266. doi: 10.1016/j.numecd.2016.11.005. Epub 2016 Nov 23.

PMID:
28017524
46.

Reappraisal in two European cohorts of the prognostic power of left ventricular mass index in chronic kidney failure.

Tripepi G, Pannier B, D'Arrigo G, Mallamaci F, Zoccali C, London G.

Kidney Int. 2017 Mar;91(3):704-710. doi: 10.1016/j.kint.2016.10.012. Epub 2016 Dec 20.

PMID:
28010886
47.

Pruritus and quality of life in renal transplant patients.

Panuccio V, Tripepi R, Bellantoni M, Saporito L, Quattrone S, Lacava V, Parlongo G, Tripepi G, Mallamaci F, Zoccali C.

Clin Transplant. 2017 Mar;31(3). doi: 10.1111/ctr.12893. Epub 2017 Jan 6.

PMID:
27988982
48.

Exercise in Patients on Dialysis: A Multicenter, Randomized Clinical Trial.

Manfredini F, Mallamaci F, D'Arrigo G, Baggetta R, Bolignano D, Torino C, Lamberti N, Bertoli S, Ciurlino D, Rocca-Rey L, Barillà A, Battaglia Y, Rapanà RM, Zuccalà A, Bonanno G, Fatuzzo P, Rapisarda F, Rastelli S, Fabrizi F, Messa P, De Paola L, Lombardi L, Cupisti A, Fuiano G, Lucisano G, Summaria C, Felisatti M, Pozzato E, Malagoni AM, Castellino P, Aucella F, Abd ElHafeez S, Provenzano PF, Tripepi G, Catizone L, Zoccali C.

J Am Soc Nephrol. 2017 Apr;28(4):1259-1268. doi: 10.1681/ASN.2016030378. Epub 2016 Dec 1. Erratum in: J Am Soc Nephrol. 2018 Jul;29(7):2028.

49.

Arterial Stiffness as a Cardiovascular Risk Factor in Stage 5D Chronic Kidney Disease Patients: An Age Affair.

Zoccali C, Mallamaci F.

Am J Nephrol. 2017;45(1):69-71. doi: 10.1159/000453339. Epub 2016 Nov 30. No abstract available.

50.

Respiratory muscle impairment in dialysis patients: can minimal dose of exercise limit the damage? A Preliminary study in a sample of patients enrolled in the EXCITE trial.

Pomidori L, Lamberti N, Malagoni AM, Manfredini F, Pozzato E, Felisatti M, Catizone L, Barillà A, Zuccalà A, Tripepi G, Mallamaci F, Zoccali C, Cogo A.

J Nephrol. 2016 Dec;29(6):863-869. Epub 2016 Jun 16.

PMID:
27312989

Supplemental Content

Loading ...
Support Center